Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Capsugel was a global leader in the design, development, and manufacturing of innovative capsule-based dosage forms and drug delivery systems. It provided end-to-end services from early-stage development through full commercialization to pharmaceutical, consumer health, OTC, and nutrition industries. The company held over 120 patents related to dosage forms and drug delivery devices. In December 2016 it was acquired by Lonza to expand Lonza’s integrated CDMO offerings. Capsugel did not conduct clinical trials or have its own therapeutic pipeline; instead it enabled client programs across all stages of development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Capsugel.